Business Wire

Tandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced its acquisition of infusion set developer, Capillary ...
Business Wire

Capillary Biomedical Reports Best-in-Class Clinical Feasibility Results for its SteadiFlow Seven-Day-Wear Infusion Set Technology at ADA Scientific Sessions

IRVINE, Calif.--(BUSINESS WIRE)--Medical device developer Capillary Biomedical, Inc. (CapBio) has presented highly favorable clinical feasibility study results for its SteadiFlow cannula technology at ...
FierceBiotech

FDA clears BD insulin infusion set developed with diabetes patient advocacy groups

Becton Dickinson ($BDX) worked with diabetes patient advocate groups to develop its latest insulin infusion set, which is designed for improved insulin flow with ...
Healio

Extended-wear insulin infusion set lasts 7 days for most wearers, with few adverse events

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A novel extended-wear insulin infusion set was usable ...
Los Angeles Business Journal

Promising Clinical Feasibility Results for Seven-Day-Wear Infusion Set Technology Announced

Medical device developer Capillary Biomedical, Inc. (CapBio) has presented highly favorable clinical feasibility study results for its SteadiFlow cannula technology at this year’s American Diabetes ...
Nasdaq

Medtronic (MDT) Boosts Diabetes Management via New Infusion Set

Medtronic plc MDT has recently launched the Medtronic Extended infusion set in select European countries. This set was developed in partnership with ConvaTec's Unomedical subsidiary, a well-known ...